Health and economic impacts of Vaccae vaccination incorporating active case finding in India and South Africa: a modelling study

在印度和南非,结合主动病例发现的疫苗接种对健康和经济的影响:一项建模研究

阅读:1

Abstract

INTRODUCTION: Tuberculosis (TB) is a major global health issue, particularly, in India and South Africa. We aim to evaluate the potential of the new TB vaccine, Vaccae, to enhance TB control by integrating with active case finding (ACF) strategies in these regions. METHODS: Using age-structured dynamic models, we projected the epidemiological and economic outcomes of combining Vaccae vaccination with ACF over 27 years. In India, four age-targeted strategies were analysed: (1) adolescent (15 years), (2) adolescent and young adult (AYA, 15-34 years), (3) adult (18-55 years) and (4) elderly (60+ years). In South Africa, strategies were based on HIV status: (1) HIV-targeted, (2) non-HIV and (3) general population. The vaccine efficacy of Vaccae was set at 54.7%, priced at US$120 per course. Outcomes measured included reductions in TB incidence and mortality, prioritised based on budget, incremental cost-effectiveness ratios (ICER) and benefit-cost ratios (BCR). RESULTS: In India, the adult strategy could prevent 8.70 (95% UI: 6.86-11.13) million TB cases and 0.61 (0.39-0.91) million deaths, reducing incidence and mortality by 20.1% (18.7%-23.5%) and 19.0% (17.5%-22.5%), respectively. In South Africa, the general population strategy could avert 0.67 (0.45-0.99) million TB cases and 0.21 (0.15-0.28) million deaths, reducing incidence by 28.1% (26.1%-30.3%) and mortality by 27.0% (23.5%-30.0%). The vaccination budgets for the AYA strategy in India and the HIV-targeted strategy in South Africa were US$14.0 (10.14-23.29) billion and US$0.09 (0.06-0.15) billion, respectively. The ICERs were US$1082 (927-1426) and US$70 (53-123) per disability-adjusted life year averted, and the BCRs were 2.0 (1.6-2.4) and 176 (83.4-255.3), respectively. Thus, the AYA strategy in India and the HIV-targeted strategy in South Africa were the most favourable. CONCLUSION: Integrating Vaccae vaccination with ACF could significantly enhance TB control in high-burden countries. Policymakers should consider these strategies, with further research needed to confirm the findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。